Eurasian Development Bank Forecasts Multi-Trillion Dollar Investment Surge Led by Biotech and Robotics Through 2035

Biotechnology and robotics lead the next global investment surge, with biotech projected to hit $5.9 trillion by 2034, per the latest EDB report.

By: AXL Media

Published: Apr 8, 2026, 5:46 AM EDT

Source: Information for this report was sourced from The Astana Times

Capital Influx Shifts Toward Longevity and Automation

The Eurasian Development Bank has signaled a fundamental shift in global capital flows, identifying seven specific sectors poised to dominate the next technological investment cycle. According to the bank's press service, the newly released Waves of Investment Megahype report outlines a roadmap where biotechnology, robotics, and autonomous systems emerge as the frontrunners for massive liquidity. This movement follows previous market peaks in digital infrastructure in 2021 and artificial intelligence in 2025, suggesting that the global economy is now entering a phase where physical and biological sciences converge with digital maturity.

Historical Precedents of the Modern Investment Cycle

The current trajectory of emerging technology is built upon the foundational infrastructure established during prior economic surges. The EDB report emphasizes that the digital boom of the early 2020s and the ESG focus of 2023 provided the necessary data and demand structures that enabled the AI wave of 2025. This cumulative effect ensures that upcoming technologies, such as quantum computing and the space economy, do not operate in a vacuum but rather utilize the scaled capabilities of their predecessors. Consequently, the bank views these cycles not as isolated bubbles but as a continuous evolution of market infrastructure.

Biotechnology as a Solution for Global Labor Demands

Among the targeted sectors, biotechnology stands out as a critical economic lever due to its potential to mitigate the impact of aging populations. The bank suggests that by extending the healthy and productive lifespans of workers, the sector addresses long-term labor shortages that threaten global productivity. Financial estimates provided by the EDB indicate the global biotech market, valued at approximately $1.9 trillion to $2.2 trillion in 2024-2025, is on a path to reach nearly $5.9 trillion by 2034. This growth reflects a broader strategic pivot where healthcare and aging prevention are treated as core economic pillars rather than just social services.